Antibiotics and Corticosteroids Industry Key Manufacturers Analysis with Sales, Price, Revenue, Gross Margin Forecasts To 2026
Antibiotics
are used to terminate the bacterial growth or bacteria itself in the
case of bacterial infection, whereas, corticosteroids are used to
treat the allergy and inflammatory condition. There are some
functions which corticosteroids can perform while antibiotics cannot
perform and vice-versa. At times, the physician prescribes the dose
of antibiotics in addition with corticosteroids so that antibiotic
will help attack the microorganism cell wall whereas the inflammatory
process can be tackled by the corticosteroids. Corticosteroids also
decreases the pain related to inflammation by inhibiting chemical
mediators. Over dosage or misuse of both compounds might lead to
adverse effects such as failure of immune system.
Efficacy of
combine treatment of antibiotics and corticosteroids on several
chronic diseases is the major factor for growth of antibiotics and
corticosteroids market
The use of
antibiotics with the combination of corticosteroids has proven
effective in the treatment of human respiratory syncytial virus
(hRSV) infection, Cepacia syndrome, S. Aureus arthritis, pneumonia,
Zika Virus, and Ebola. According to the data published in Journal of
Tropical Diseases and Public Health, in 2016, around 6.3 million
children died in 2013, wherein 51.8% died due to infectious diseases
and largest was accounted due to pneumonia for around 935,000 deaths.
However, around 3.4 million children are infected with the human
Respiratory syncytial virus (RSV) which is associated to acute lower
respiratory infections (ALRI). Supportive government activities in
the favor of antibiotics and corticosteroids production is helping to
boost the antibiotic and corticosteroids market. For instance,
introduction of Antibiotics Incentives Now (GAIN) act which has the
provisions to facilitate the development of therapy against antigen
resistant pathogens is expected to propel the approval for
antibiotics.
However, some of the
restraints which are likely to hamper the growth of antibiotics and
corticosteroids market include the adverse effect on high intake or
misuse of both antibiotics and corticosteroids, use in animals which
are later consumed by humans, and regulations and policies on use of
antibiotics and corticosteroids.
Rise in
population with pneumonia is contributing to the growth of this
disease segment in antibiotics and corticosteroids market
The global
antibiotics and corticosteroids market is segmented by application,
by antibiotics type, by end user, by disease type, and by region
On the basis of
application, the antibiotics and corticosteroids market is segmented
into
Humans
Veterinary
On the basis of
antibiotic type, the antibiotics and corticosteroids market is
segmented into
Macrolides
Tetracycline
Beta-lactams
Lincosamides
Glycopeptides
Aminoglycosides
Sulfonamides
Others
On the basis of end
user, the antibiotics and corticosteroids market is segmented into
Hospitals
Medical clinics
On the basis of
disease type, the antibiotics and corticosteroids market is segmented
into
Pneumonia
Cepasia Syndrome
Human
Respiratory syncytial virus (RSV) infection
Aureus Arthritis
Sinus Infection
Others
Rising cases of
infectious diseases and established healthcare sector is fuelling to
the growth of antibiotics and corticosteroids market in North America
Regional
segmentation of antibiotics and corticosteroids market by Coherent
Market Insights comprises of North America, Latin America, Europe,
Asia Pacific, the Middle East and Africa. North America hold the
major share in the antibiotics and corticosteroids market due to the
high prevalence rate of respiratory syncytial virus (RSV) infection
and the need of antibiotic and corticosteroids treatment of such
diseases. For instance, the data given by Centers for Disease Control
and Prevention (CDC), around 2.1 million children are diagnosed with
RSV and 14, 000 adult population die due to this disease annually.
Latin America also hold the large share in the antibiotics and
corticosteroids market followed by Asia Pacific due to the progress
in pharmaceutical industry.
Request For
Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/781
Industry players
are involved in the regional expansion and collaborations with other
companies to hold the larger share in the antibiotics and
corticosteroids market
Key industry players
operating the global antibiotics and corticosteroids market include
Novartis, Pfizer, GlaxoSmithKline (GSK), Abbott Laboratories, Sanofi,
Johnson & Johnson, Merck, Sumitomo, AstraZeneca, Cipla, and
Astellas Pharma. The generic drug manufacturers are dominating in the
antibiotics and corticosteroid market due to the presence of key
drugs that are helping to generate the revenue with availability of
few patent products. Adoption of various strategies such as regional
expansion, novel product development, collaborations, and
partnerships by the industry players to hold the major share in the
antibiotics and corticosteroids market. For instance, Pfizer made an
agreement with AstraZeneca in 2016, which has helped to acquire the
commercialization and development right to the Pfizer’s business
mostly outside the U.S.
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Comments
Post a Comment